Timing of Antiretroviral Treatment, Immunovirologic Status and TB Risk

Journal of Acquired Immune Deficiency Syndromes - United States
doi 10.1097/qai.0000000000001018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

The Impact of HIV and Antiretroviral Therapy on TB Risk in Children: A Systematic Review and Meta-Analysis

Thorax
PulmonaryRespiratory Medicine
2017English

Changes to Antiretroviral Drug Regimens During Integrated TB–HIV Treatment: Results of the SAPiT Trial

Antiviral Therapy
Infectious DiseasesPharmacology
2014English

Considerations in the Rationale, Design and Methods of the Strategic Timing of AntiRetroviral Treatment (START) Study

Clinical Trials
MedicinePharmacology
2012English

Relationship Between TB Treatment Phase and Knowledge of MDR TB With TB Patient’s Compliance

Jurnal Berkala Epidemiologi
2017English

Correction: Should Expectations About the Rate of New Antiretroviral Drug Development Impact the Timing of HIV Treatment Initiation and Expectations About Treatment Benefits?

PLoS ONE
Multidisciplinary
2014English

Improper Anti-Tb Treatment- Almost Certain Recipe for MDR-Tb

Journal of Evolution of Medical and Dental Sciences
2018English

Current Status of Oligometastatic Prostate Cancer: Risk Factors and Treatment Approaches

The Bulletin of Urooncology
2018English

Predictors of Early Mortality and Effectiveness of Antiretroviral Therapy in TB-HIV Patients From Brazil

PLoS ONE
Multidisciplinary
2019English

Antiretroviral-Based HIV-1 Prevention: Antiretroviral Treatment and Pre-Exposure Prophylaxis

Antiviral Therapy
Infectious DiseasesPharmacology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy